Investor Perspectives – How to Solve the Biotech/Life Sciences Problem: Changes Expected in the Sector in the Coming 12 Months

This is Investor Perspectives. I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.

In our new Investor Perspectives series entitled “How to Solve the Biotech/Life Sciences Problem”, you’ll hear about changes expected in the Biotech/Life Sciences sector in the coming 12 months.

As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up.

Our guests are:

Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels 01:16
Carter Williams, CEO and Managing Partner, iSelect Fund 05:08
Maximilian Bade, Founding Partner, Nucleus Capital 12:06
Ron Paliwoda, President, Paliwoda Group 15:44
Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund 24:21
Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures 27:28
Mark Groper, Chief Executive Officer, Orion Biotechnology 30:22

We hope you enjoy the show.
_______________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org     

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/ 
For Startups check out: https://tencapital.group/company-landing/  
For eGuides check out: https://tencapital.group/education/ 
For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact [e-mail]  

Music courtesy of Bensound